PubRank

Piotr Hadaczek

Author PubWeight™ 19.57‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Efficient gene therapy-based method for the delivery of therapeutics to primate cortex. Proc Natl Acad Sci U S A 2009 1.70
2 Extensive distribution of liposomes in rodent brains and brain tumors following convection-enhanced delivery. J Neurooncol 2004 1.61
3 Cerebral infusion of AAV9 vector-encoding non-self proteins can elicit cell-mediated immune responses. Mol Ther 2012 1.55
4 Real-time MR imaging of adeno-associated viral vector delivery to the primate brain. Neuroimage 2008 1.53
5 Safety evaluation of AAV2-GDNF gene transfer into the dopaminergic nigrostriatal pathway in aged and parkinsonian rhesus monkeys. Hum Gene Ther 2009 1.46
6 Anterograde axonal transport of AAV2-GDNF in rat basal ganglia. Mol Ther 2010 1.32
7 Clinically relevant effects of convection-enhanced delivery of AAV2-GDNF on the dopaminergic nigrostriatal pathway in aged rhesus monkeys. Hum Gene Ther 2009 1.21
8 Regeneration of the MPTP-lesioned dopaminergic system after convection-enhanced delivery of AAV2-GDNF. J Neurosci 2010 1.14
9 Real-time MR imaging with Gadoteridol predicts distribution of transgenes after convection-enhanced delivery of AAV2 vectors. Mol Ther 2010 1.09
10 Image-guided convection-enhanced delivery of GDNF protein into monkey putamen. Neuroimage 2010 1.02
11 Human interleukin-10 gene transfer is protective in a rat model of Parkinson's disease. Mol Ther 2008 0.98
12 Controlled dissemination of AAV vectors in the primate brain. Prog Brain Res 2009 0.93
13 Non-PEGylated liposomes for convection-enhanced delivery of topotecan and gadodiamide in malignant glioma: initial experience. J Neurooncol 2009 0.90
14 Cytogenetic and molecular findings in 75 clear cell renal cell carcinomas. Oncol Rep 2005 0.89
15 Distribution of acid sphingomyelinase in rodent and non-human primate brain after intracerebroventricular infusion. Exp Neurol 2011 0.89
16 Pharmacokinetics, tumor accumulation and antitumor activity of nanoliposomal irinotecan following systemic treatment of intracranial tumors. Nanomedicine (Lond) 2014 0.76
17 Systemic rapamycin alone may not be a treatment option for malignant glioma: evidence from an in vivo study. J Neurooncol 2012 0.75